AstraZeneca PLC AZN.ST Stock
AstraZeneca PLC Price Chart
AstraZeneca PLC AZN.ST Financial and Trading Overview
AstraZeneca PLC stock price | 1657.5 SEK |
Previous Close | 1563 SEK |
Open | 1562 SEK |
Bid | 1584 SEK x 0 |
Ask | 1584.5 SEK x 0 |
Day's Range | 1561 - 1587.5 SEK |
52 Week Range | 1200.5 - 1614 SEK |
Volume | 224.38K SEK |
Avg. Volume | 246.8K SEK |
Market Cap | 2.46T SEK |
Beta (5Y Monthly) | 0.194636 |
PE Ratio (TTM) | 48.307926 |
EPS (TTM) | 44.11 SEK |
Forward Dividend & Yield | 30.15 (1.92%) |
Ex-Dividend Date | February 23, 2023 |
1y Target Est | 1392.69 SEK |
AZN.ST Valuation Measures
Enterprise Value | 2.48T SEK |
Trailing P/E | 48.307926 |
Forward P/E | 17.672318 |
PEG Ratio (5 yr expected) | 0.02 |
Price/Sales (ttm) | 56.01663 |
Price/Book (mrq) | 68.57823 |
Enterprise Value/Revenue | 56.579 |
Enterprise Value/EBITDA | 166.628 |
Trading Information
AstraZeneca PLC Stock Price History
Beta (5Y Monthly) | 0.194636 |
52-Week Change | 27.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1614 SEK |
52 Week Low | 1200.5 SEK |
50-Day Moving Average | 1540.23 SEK |
200-Day Moving Average | 1403.8 SEK |
AZN.ST Share Statistics
Avg. Volume (3 month) | 246.8K SEK |
Avg. Daily Volume (10-Days) | 219.53K SEK |
Shares Outstanding | 1.55B |
Float | 1.54B |
Short Ratio | N/A |
% Held by Insiders | 0.23% |
% Held by Institutions | 50.59% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.9 |
Trailing Annual Dividend Yield | 0.18% |
5 Year Average Dividend Yield | 268.00% |
Payout Ratio | 0.945 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 10.73% |
Operating Margin (ttm) | 23.09% |
Gross Margin | 84.30% |
EBITDA Margin | 33.95% |
Management Effectiveness
Return on Assets (ttm) | 6.42% |
Return on Equity (ttm) | 13.05% |
Income Statement
Revenue (ttm) | 43.84B SEK |
Revenue Per Share (ttm) | 28.32 SEK |
Quarterly Revenue Growth (yoy) | -4.50% |
Gross Profit (ttm) | 35.73B SEK |
EBITDA | 14.89B SEK |
Net Income Avi to Common (ttm) | 4.7B SEK |
Diluted EPS (ttm) | 32.8 |
Quarterly Earnings Growth (yoy) | 367.09% |
Balance Sheet
Total Cash (mrq) | 6.46B SEK |
Total Cash Per Share (mrq) | 4.17 SEK |
Total Debt (mrq) | 32.47B SEK |
Total Debt/Equity (mrq) | 90.68 SEK |
Current Ratio (mrq) | 0.896 |
Book Value Per Share (mrq) | 23.105 |
Cash Flow Statement
Operating Cash Flow (ttm) | 9.71B SEK |
Levered Free Cash Flow (ttm) | 9.69B SEK |
Profile of AstraZeneca PLC
Country | Sweden |
State | N/A |
City | Cambridge |
Address | 1 Francis Crick Avenue |
ZIP | CB2 0AA |
Phone | 44 20 3749 5000 |
Website | https://www.astrazeneca.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 83500 |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Q&A For AstraZeneca PLC Stock
What is a current AZN.ST stock price?
AstraZeneca PLC AZN.ST stock price today per share is 1657.5 SEK.
How to purchase AstraZeneca PLC stock?
You can buy AZN.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AstraZeneca PLC?
The stock symbol or ticker of AstraZeneca PLC is AZN.ST.
Which industry does the AstraZeneca PLC company belong to?
The AstraZeneca PLC industry is Drug Manufacturers-General.
How many shares does AstraZeneca PLC have in circulation?
The max supply of AstraZeneca PLC shares is 1.54B.
What is AstraZeneca PLC Price to Earnings Ratio (PE Ratio)?
AstraZeneca PLC PE Ratio is 37.31580000 now.
What was AstraZeneca PLC earnings per share over the trailing 12 months (TTM)?
AstraZeneca PLC EPS is 44.11 SEK over the trailing 12 months.
Which sector does the AstraZeneca PLC company belong to?
The AstraZeneca PLC sector is Healthcare.
AstraZeneca PLC AZN.ST included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
OMX Nordic 40 OMXN40 | 2739.03 EUR 2994.12 USD |
+0.2
|
— — | — — | — — | — - | — — |
OMX Stockholm 30 Index OMX | 2506.99 SEK 244.71 USD |
+0.29
|
— — | — — | — — | — - | — — |
NASDAQ OMX Nordic 120 Net Index NOMXN120NI | 2320.95 EUR 2537.11 USD |
+0.24
|
— — | — — | — — | — - | — — |
OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
OMX Stockholm Benchmark_GI OMXSBGI | 1880.94 SEK 183.6 USD |
+0.12
|
— — | — — | — — | — - | — — |
OMX Stockholm 50 Equal Weighted OMXS50EW | 1067.36 SEK 104.19 USD |
-0.1
|
— — | — — | — — | — - | — — |
XCSE:OMX Stockholm 30 Index OMXS30 | 2506.99 SEK 244.71 USD |
+0.29
|
— — | 2503.5 SEK 244.37 USD | 2540.53 SEK 247.99 USD | — - | — — |
OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
NASDAQ OMX Nordic 120 SEK Net I NOMXN120SEKNI | 2582.04 SEK 252.04 USD |
+0.74
|
— — | — — | — — | — - | — — |
NASDAQ OMX Nordic 120 NOMXN120 | 1615.32 EUR 1765.76 USD |
+0.22
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
OMX Stockholm Benchmark Cap_GI OMXSBCAPGI | 2194.32 SEK 214.19 USD |
+0.11
|
— — | — — | — — | — - | — — |
OMX Stockholm 30 Ask OMXS30ASK | 2506.57 SEK 244.67 USD |
+0.4
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}